Their combined offering will provide customers with a single solution for managing lab operations and performing sequence analysis and mutation identification.
NEW YORK (GenomeWeb) – OncoCyte and Abcodia today announced they will collaborate on the development of OncoCyte's gene expression-based diagnostic test for the early detection of breast cancer.
NEW YORK (GenomeWeb) – BioTime subsidiary OncoCyte has entered into a deal with Cornell University to collaborate on developing a lung cancer diagnostic test, the parties announced today.
NEW YORK (GenomeWeb News) – BioTime subsidiary OncoCyte today announced that it will collaborate with the Wistar Institute on the development of a gene expression-based lung cancer test.
NEW YORK (GenomeWeb News) – Cloud computing company Appistry today announced a partnership and reseller agreement to integrate LifeMap Sciences' databases into the outputs of genomics pipelines running on Appistry's Ayrris computing environment.
NEW YORK (GenomeWeb News) – LifeMap Sciences today announced an exclusive distribution deal with ProSpec-Tany TechnoGene to offer more than 1,000 recombinant proteins and antibodies.
NEW YORK (GenomeWeb News) – NanoString Technologies has obtained the CE Mark for its PAM50-based gene expression test for breast cancer, clearing the firm to sell the test in the European Union and other countries that recognize the CE Mark.
In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.
